Cargando…
Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients
OBJECTIVES: This retrospective cohort study investigates outcomes of patients with intermediate-high and high-risk pulmonary embolism (PE) who were treated with transfemoral mechanical thrombectomy (MT) using the large-bore Inari FlowTriever aspiration catheter system. MATERIAL AND METHODS: Twenty-s...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521880/ https://www.ncbi.nlm.nih.gov/pubmed/36175655 http://dx.doi.org/10.1007/s00270-022-03266-0 |
_version_ | 1784799939818160128 |
---|---|
author | Luedemann, W. M. Zickler, D. Kruse, J. Koerner, R. Lenk, J. Erxleben, C. Torsello, G. F. Fehrenbach, U. Jonczyk, M. Guenther, R. W. De Bucourt, M. Gebauer, B. |
author_facet | Luedemann, W. M. Zickler, D. Kruse, J. Koerner, R. Lenk, J. Erxleben, C. Torsello, G. F. Fehrenbach, U. Jonczyk, M. Guenther, R. W. De Bucourt, M. Gebauer, B. |
author_sort | Luedemann, W. M. |
collection | PubMed |
description | OBJECTIVES: This retrospective cohort study investigates outcomes of patients with intermediate-high and high-risk pulmonary embolism (PE) who were treated with transfemoral mechanical thrombectomy (MT) using the large-bore Inari FlowTriever aspiration catheter system. MATERIAL AND METHODS: Twenty-seven patients (mean age 56.1 ± 15.3 years) treated with MT for PE between 04/2021 and 11/2021 were reviewed. Risk stratification was performed according to European Society of Cardiology (ESC) guidelines. Clinical and hemodynamic characteristics before and after the procedure were compared with the paired Student’s t test, and duration of hospital stay was analyzed with the Kaplan–Meier estimator. Procedure-related adverse advents were assessed. RESULTS: Of 27 patients treated, 18 were classified as high risk. Mean right-to-left ventricular ratio on baseline CT was 1.7 ± 0.6. After MT, a statistically significant reduction in mean pulmonary artery pressures from 35.9 ± 9.6 to 26.1 ± 9.0 mmHg (p = 0.002) and heart rates from 109.4 ± 22.5 to 82.8 ± 13.8 beats per minute (p < 0.001) was achieved. Two patients died of prolonged cardiogenic shock. Three patients died of post-interventional complications of which a paradoxical embolism can be considered related to MT. One patient needed short cardiopulmonary resuscitation during the procedure due to clot displacement. Patients with PE as primary driver of clinical instability had a median intensive care unit (ICU) stay of 2 days (0.5–3.5 days). Patients who developed PE as a complication of an underlying medical condition spent 11 days (9.5–12.5 days) in the ICU. CONCLUSION: In this small study population of predominantly high-risk PE patients, large-bore MT without adjunctive thrombolysis was feasible with an acceptable procedure-related complication rate. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00270-022-03266-0. |
format | Online Article Text |
id | pubmed-9521880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95218802022-09-30 Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients Luedemann, W. M. Zickler, D. Kruse, J. Koerner, R. Lenk, J. Erxleben, C. Torsello, G. F. Fehrenbach, U. Jonczyk, M. Guenther, R. W. De Bucourt, M. Gebauer, B. Cardiovasc Intervent Radiol Clinical Investigation OBJECTIVES: This retrospective cohort study investigates outcomes of patients with intermediate-high and high-risk pulmonary embolism (PE) who were treated with transfemoral mechanical thrombectomy (MT) using the large-bore Inari FlowTriever aspiration catheter system. MATERIAL AND METHODS: Twenty-seven patients (mean age 56.1 ± 15.3 years) treated with MT for PE between 04/2021 and 11/2021 were reviewed. Risk stratification was performed according to European Society of Cardiology (ESC) guidelines. Clinical and hemodynamic characteristics before and after the procedure were compared with the paired Student’s t test, and duration of hospital stay was analyzed with the Kaplan–Meier estimator. Procedure-related adverse advents were assessed. RESULTS: Of 27 patients treated, 18 were classified as high risk. Mean right-to-left ventricular ratio on baseline CT was 1.7 ± 0.6. After MT, a statistically significant reduction in mean pulmonary artery pressures from 35.9 ± 9.6 to 26.1 ± 9.0 mmHg (p = 0.002) and heart rates from 109.4 ± 22.5 to 82.8 ± 13.8 beats per minute (p < 0.001) was achieved. Two patients died of prolonged cardiogenic shock. Three patients died of post-interventional complications of which a paradoxical embolism can be considered related to MT. One patient needed short cardiopulmonary resuscitation during the procedure due to clot displacement. Patients with PE as primary driver of clinical instability had a median intensive care unit (ICU) stay of 2 days (0.5–3.5 days). Patients who developed PE as a complication of an underlying medical condition spent 11 days (9.5–12.5 days) in the ICU. CONCLUSION: In this small study population of predominantly high-risk PE patients, large-bore MT without adjunctive thrombolysis was feasible with an acceptable procedure-related complication rate. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00270-022-03266-0. Springer US 2022-09-29 2023 /pmc/articles/PMC9521880/ /pubmed/36175655 http://dx.doi.org/10.1007/s00270-022-03266-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Investigation Luedemann, W. M. Zickler, D. Kruse, J. Koerner, R. Lenk, J. Erxleben, C. Torsello, G. F. Fehrenbach, U. Jonczyk, M. Guenther, R. W. De Bucourt, M. Gebauer, B. Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title | Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title_full | Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title_fullStr | Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title_full_unstemmed | Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title_short | Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients |
title_sort | percutaneous large-bore pulmonary thrombectomy with the flowtriever device: initial experience in intermediate-high and high-risk patients |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521880/ https://www.ncbi.nlm.nih.gov/pubmed/36175655 http://dx.doi.org/10.1007/s00270-022-03266-0 |
work_keys_str_mv | AT luedemannwm percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT zicklerd percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT krusej percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT koernerr percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT lenkj percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT erxlebenc percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT torsellogf percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT fehrenbachu percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT jonczykm percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT guentherrw percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT debucourtm percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients AT gebauerb percutaneouslargeborepulmonarythrombectomywiththeflowtrieverdeviceinitialexperienceinintermediatehighandhighriskpatients |